strokes Tagged Articles
UK advisory panel recommends approval of controversial Pradaxa
Boehringer Ingelheim GmbH’s blood thinner Pradaxa has won the recommendation from the United Kingdom’s medical-cost regulator as a treatment to prevent strokes in patients with a life threatening type of irregular heartbeat. The recommendation was made in spite of concerns
Bayer settles a small fraction of Yaz, Yasmin lawsuits
Bayer has agreed to settle about 70 of the approximately 11,300 lawsuits against the drug giant involving its blockbuster birth control pills Yaz and Yasmin, according to the company’s 2011 annual report. The terms of the settlement were not disclosed,
Panel members had financial ties to Yaz maker
Why are the birth control pills Yaz and Yasmin still on the market when studies show they are more dangerous than other oral contraceptives?
Generic Yaz will include same blood clot warnings
Watson Pharmaceuticals has launched Vestura, a generic version of Bayer’s blockbuster birth control pill Yaz. Like their brand-name counterpart, these pills will also carry a safety announcement on their packaging, warning users that studies suggest the drospirenone-containing pills may put
FDA panel member ‘well utilized’ by Yaz maker
A Food and Drug Administration (FDA) panel member who voted to keep the birth control pills Yaz and Yasmin on the market despite studies that showed the pills put women at greater risk for deadly blood clots was praised by
Drug companies may delay, withhold trial data from medical journals
Missing data from clinical trials that test the safety and efficacy of pharmaceutical drugs “distorts scientific record” and puts patients lives in danger, the British Medical Journal warns. The medical publication, which serves as a resource for policy makers and
Pros and cons of birth control pills for nuns
For centuries, nuns have been at greater risk for developing breast, ovarian and uterine cancers – diseases that are more common in women who do not have children. But a new study published in The Lancet suggests nuns could greatly
FDA panel warns of elevated blood clot risk with patch, Yaz
A Food and Drug Administration (FDA) advisory panel said Friday that the Ortho Evra birth control patch, made by Johnson & Johnson, should remain on the market despite an elevated risk for blood clots. The panel voted 19-5 in favor
Blood clot warnings on birth control pills could impact user rates
Stronger warnings on packages of a newer class of birth control pills and government ruling to restrict the availability of the morning-after pill may make women leery of birth control in general, which could increase the rate of unwanted pregnancies
Why would FDA panel not ban Yaz over blood clot risk?
Why did an advisory panel of experts for the Food and Drug Administration (FDA) not vote to ban the popular birth control pill Yaz and other pills of its generation containing the hormone drospirenone, instead opting to recommend that the
